News & Events

Sydney Neuroimaging Analysis Centre (SNAC) is proud to announce the enterprise deployment of the iQ-solutions™ platform across the I-MED Radiology network, strengthening access to quantitative brain MRI analysis for clinicians and patients across Australia.

With iQ-MS™ and iQ-COG™ now integrated into I-MED’s neuroimaging workflows, radiologists and referrers can access quantitative brain MRI insights that support detailed reporting and complement the assessment and longitudinal monitoring of neurological conditions, including multiple sclerosis and cognitive dysfunction in the setting of neurodegenerative disease and related conditions.

SNAC’s iQ-solutions™ is a medical imaging software platform listed on the Australian Register of Therapeutic Goods, ARTG 456068. It is intended for automatic annotation, visualisation and quantification of segmentable brain structures from brain MRI scans, including cross-sectional structure segmentation and volume analysis, and longitudinal volume change analysis where compatible prior imaging is available. Outputs are provided as an adjunct to radiologist interpretation and should be considered within the broader clinical context.

iQ-MS™ provides quantitative information on white matter lesion burden, lesion distribution, relevant brain structures and longitudinal change where compatible prior imaging is available. These outputs may assist radiologists and treating clinicians when assessing disease burden and interval change over time.

iQ-COG™ provides volumetric analysis of regional brain structures compared against age-matched normative data, offering objective metrics to assist radiologists and clinicians when interpreting atrophy patterns in the broader clinical context.

John Moulden, Chief Commercial Officer of SNAC, said:

“The enterprise deployment of iQ-solutions™ across I-MED’s MRI network represents a significant milestone for quantitative neuroimaging in Australia. By making objective brain MRI metrics available through Australia’s largest medical imaging network, I-MED is helping clinicians access additional insights to support the assessment and longitudinal monitoring of neurological conditions. SNAC is proud to support this initiative with technology that complements expert radiologist interpretation and contributes to more informed management of conditions such as multiple sclerosis and cognitive dysfunction in the setting of neurodegenerative disease.”

I-MED Chief Medical Officer, Dr Luke Danaher said:

“At I-MED, we are committed to delivering high-quality diagnostic imaging supported by evidence-based innovation. Integrating SNAC’s iQ-solutions™ platform across our network enhances our ability to provide quantitative brain MRI insights for our referrers and patients. These tools provide data that complement clinical decision-making and add meaningful value to the long-term management of neurological conditions.”

With this technology now available at over 100 I-MED clinics offering MRI services, clinicians across Australia have improved access to quantitative neuroimaging tools.

By integrating advanced quantitative analysis with I-MED’s sub-specialist radiologist expertise, this platform provides objective metrics to assist radiologists and clinicians in the assessment and longitudinal monitoring of neurological conditions.

SNAC iQ-solutions™ is a medical imaging software platform listed on the Australian Register of Therapeutic Goods, ARTG 456068. It is intended for automatic annotation, visualisation and quantification of segmentable brain structures from brain MRI scans. Reports are provided as an adjunct to radiologist interpretation and should be considered within the broader clinical context. The platform includes iQ-MS™ and iQ-COG™ modules that support quantitative brain MRI analysis in the context of multiple sclerosis and cognitive dysfunction associated with neurodegenerative disease and related conditions.